BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10799716)

  • 1. Sphingomyelin metabolites in vascular cell signaling and atherogenesis.
    Augé N; Nègre-Salvayre A; Salvayre R; Levade T
    Prog Lipid Res; 2000 May; 39(3):207-29. PubMed ID: 10799716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipids in atherosclerosis and vascular biology.
    Chatterjee S
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1523-33. PubMed ID: 9763522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingolipids in mammalian cell signalling.
    Ohanian J; Ohanian V
    Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies.
    Kitatani K; Taniguchi M; Okazaki T
    Mol Cells; 2015 Jun; 38(6):482-95. PubMed ID: 25997737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipids and cell signaling: involvement in apoptosis and atherogenesis.
    Ipatova OM; Torkhovskaya TI; Zakharova TS; Khalilov EM
    Biochemistry (Mosc); 2006 Jul; 71(7):713-22. PubMed ID: 16903825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the signal transduction of ceramide and related sphingolipids.
    Liu G; Kleine L; Hébert RL
    Crit Rev Clin Lab Sci; 1999 Dec; 36(6):511-73. PubMed ID: 10656539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sphingolipid-mediated apoptotic signaling pathways].
    Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
    J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entamoeba invadens: sphingolipids metabolic regulation is the main component of a PKC signaling pathway in controlling cell growth and proliferation.
    Cerbon J; Olguin T; Alvarez-Grave PR; López-Sánchez RC
    Exp Parasitol; 2009 Jun; 122(2):106-11. PubMed ID: 19249300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipid metabolism and cell growth regulation.
    Spiegel S; Merrill AH
    FASEB J; 1996 Oct; 10(12):1388-97. PubMed ID: 8903509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipid signaling and redox regulation.
    Won JS; Singh I
    Free Radic Biol Med; 2006 Jun; 40(11):1875-88. PubMed ID: 16716889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
    Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
    Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 signaling in vascular cells: a key role in atherosclerosis?
    Mach F; Schönbeck U; Libby P
    Atherosclerosis; 1998 Apr; 137 Suppl():S89-95. PubMed ID: 9694547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation.
    Edsfeldt A; Dunér P; Ståhlman M; Mollet IG; Asciutto G; Grufman H; Nitulescu M; Persson AF; Fisher RM; Melander O; Orho-Melander M; Borén J; Nilsson J; Gonçalves I
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1132-40. PubMed ID: 27055903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive Sphingolipids as Major Regulators of Coronary Artery Disease.
    Song JH; Kim GT; Park KH; Park WJ; Park TS
    Biomol Ther (Seoul); 2021 Jul; 29(4):373-383. PubMed ID: 33903284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids.
    Hannun YA; Linardic CM
    Biochim Biophys Acta; 1993 Dec; 1154(3-4):223-36. PubMed ID: 8280742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
    Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
    Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of bioactive lipid signalling: lessons from sphingolipids.
    Hannun YA; Obeid LM
    Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells.
    Loidl A; Claus R; Ingolic E; Deigner HP; Hermetter A
    Biochim Biophys Acta; 2004 Oct; 1690(2):150-8. PubMed ID: 15469904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
    Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
    Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.